News
Understanding the interaction between light and matter at the smallest scales (angstrom scale) is essential for advancing ...
Van Andel Institute scientists have developed an improved technique to comprehensively profile DNA methylation in single ...
Sellas Life Sciences’ investigational CDK9 inhibitor has scored in a midstage acute myeloid leukemia (AML) study, demonstrating an overall response rate (ORR) more than double the 20% goal.
A new study done by scientists in Switzerland and Sweden investigated the use of automated systems to develop multispecific antibodies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results